Literature DB >> 28116562

Normothermic and Hyperthermic Intraperitoneal Chemoperfusions with Cisplatin to Treat Advanced Ovarian Cancer in Experimental Settings.

G S Kireeva1,2, V G Bespalov3,4, O A Belyaeva3,4, K Y Senchik3, A N Stukov3, G I Gafton3, K D Guseynov3, A M Belyaev3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28116562     DOI： 10.1007/s12253-017-0202-x

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


× No keyword cloud information.
  3 in total

Review 1.  Peritonectomy procedures.

Authors:  Paul H Sugarbaker
Journal:  Surg Oncol Clin N Am       Date:  2003-07       Impact factor: 3.495

2.  Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC).

Authors:  S Zeamari; B Floot; N van der Vange; F A Stewart
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

Review 3.  Intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis: review of animal models.

Authors:  Félix Gremonprez; Wouter Willaert; Wim Ceelen
Journal:  J Surg Oncol       Date:  2013-10-12       Impact factor: 3.454
  3 in total
  1 in total

1.  Long term survival of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in advanced epithelial ovarian cancer.

Authors:  Jue Zhang; Xin-Bao Li; Ru Ma; Zhong-He Ji; Wenpei Bai; Yan Li
Journal:  Transl Cancer Res       Date:  2021-08       Impact factor: 1.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.